Insider · CIK 0001654909

Bauer Jake

Reports to the SEC for 6 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001654909

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.7K sh	—	—	31,675
2026-04-07	IMVTImmunovant, Inc.A Award	Director	AAward	+13.9K sh	—	—	38,896
2026-04-07	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,061 sh	—	—	7,061
2026-02-12	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.1K sh	—	—	17,126
2025-08-26	BBOTBridgeBio Oncology Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+138K sh	—	—	138,193
2025-05-01	IMVTImmunovant, Inc.A Award	Director	AAward	+25K sh	—	—	25,016
2025-05-01	IMVTImmunovant, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35.2K sh	—	—	35,234
2025-02-06	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,491
2024-02-13	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.4K sh	—	—	23,364
2024-02-13	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.8K sh	—	—	16,835
2023-02-23	ELVNEnliven Therapeutics, Inc.A Award	Director	AAward	+87.4K sh	—	—	87,372
2023-02-23	ELVNEnliven Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+17.7K sh	—	—	17,706
2023-02-23	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.6K sh	—	—	27,567
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−8,748 sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Chief Business Officer	UDisposition from Tender	−90.2K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−16.5K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−35.2K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−57.4K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−34K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−45.2K sh	—	—	0
2020-04-30	MyoKardia, Inc.A Award	Chief Business Officer	AAward	+293 sh	$50.41	+$14.8K	57,784
2020-02-14	MyoKardia, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+45.2K sh	—	—	45,193
2020-02-14	MyoKardia, Inc.Restricted Stock UnitsA Award	Chief Business Officer	AAward	+14.6K sh	—	—	14,591
2020-01-06	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−2,466 sh	$68.45	−$169K	57,491
2020-01-03	MyoKardia, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	6,326
2020-01-03	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$1.51	+$15.1K	59,957
2020-01-01	MyoKardia, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−1,425 sh	—	—	2,850
2020-01-01	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+6,375 sh	—	—	49,957
2020-01-01	MyoKardia, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,950 sh	—	—	14,850
2019-12-20	MyoKardia, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	8,748
2019-12-20	MyoKardia, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−7,500 sh	—	—	0
2019-12-20	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+7,500 sh	$13.90	+$104K	62,498
2019-12-20	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$9.08	+$90.8K	54,998
2019-12-20	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−18.9K sh	$70.07	−$1.33M	43,582
2019-11-29	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−800 sh	$66.32	−$53.1K	44,998
2019-11-29	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−7,336 sh	$65.52	−$481K	45,798
2019-11-27	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−13.1K sh	$65.13	−$853K	53,134
2019-10-31	MyoKardia, Inc.A Award	Chief Business Officer	AAward	+162 sh	$40.07	+$6,491.178	66,230
2019-09-20	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+10K sh	$9.08	+$90.8K	76,068
2019-09-20	MyoKardia, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−9,700 sh	—	—	40,150
2019-09-20	MyoKardia, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−10K sh	—	—	18,748
2019-09-20	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−19.7K sh	$60.09	−$1.18M	66,068
2019-09-20	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+9,700 sh	$12.25	+$119K	85,768
2019-04-30	MyoKardia, Inc.A Award	Chief Business Officer	AAward	+313 sh	$40.78	+$12.8K	66,068
2019-02-08	MyoKardia, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+57.4K sh	—	—	57,400
2019-02-08	MyoKardia, Inc.Restricted Stock UnitsA Award	Chief Business Officer	AAward	+19.8K sh	—	—	19,800
2019-01-07	MyoKardia, Inc.F Tax Payment	Chief Business Officer	FTax Payment	−570 sh	$42.98	−$24.5K	60,755
2019-01-01	MyoKardia, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−1,425 sh	—	—	4,275
2019-01-01	MyoKardia, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+1,425 sh	—	—	61,325
2018-11-02	MyoKardia, Inc.S Sale	Chief Business Officer	SSale	−978 sh	$55.45	−$54.2K	59,900

Recent filings

Accepted (ET)
Jun 184
Bauer Jake0001193125-26-276035
SEC(opens sec.gov)
Apr 94
Bauer Jake0001764013-26-000044
SEC(opens sec.gov)
Feb 174
Bauer Jake0001654909-26-000001
SEC(opens sec.gov)
Aug 284
Bauer Jake0000950170-25-112008
SEC(opens sec.gov)
May 54
Bauer Jake0001415889-25-012046
SEC(opens sec.gov)
Feb 104
Bauer Jake0001415889-25-003517
SEC(opens sec.gov)
Feb 204/A
Bauer Jake0001415889-24-004484
SEC(opens sec.gov)
Feb 154
Bauer Jake0001415889-24-004010
SEC(opens sec.gov)
Apr 64
Bauer Jake0001209191-23-023662
SEC(opens sec.gov)
Feb 274
Bauer Jake0001209191-23-013515
SEC(opens sec.gov)
Nov 194
Bauer Jake0000899243-20-031756
SEC(opens sec.gov)

Companies

Address

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 256 EAST GRAND AVENUE, SUITE 104

SOUTH SAN FRANCISCO, CA, 94080